Burning, shooting, electric shock‑like pain — that's neuropathic pain, caused by nerve damage from diabetes, shingles, chemotherapy, or injury. It's notoriously difficult to treat. The pain management market research study shows that neuropathic pain is the fastest‑growing application, with a CAGR above 6%. Why? Because the number of people with diabetes (a major cause of neuropathy) is exploding, and cancer survivors are living longer with chemo‑induced neuropathy.

What works? Anticonvulsants (gabapentin, pregabalin), antidepressants (duloxetine, amitriptyline), and topical lidocaine. The pain management market trends highlight that the fastest‑growing route of administration is topical — creams and patches that deliver medication directly to the painful area, avoiding systemic side effects.

But neuropathic pain is stubborn. Many patients try multiple drugs before finding relief. And side effects (dizziness, sedation) can be limiting.

The message: if you have neuropathic pain, be patient. Work with your doctor to find the right combination. And don't ignore non‑drug options like TENS units, acupuncture, or CBT.